Liaoning Chengda Biotechnology Co., Ltd. (SHSE: 688739)
Health Care · Biotechnology · CN
CN¥20.68
-0.86% today · -29.8% 1Y
Liaoning Chengda Biotechnology Co., Ltd. (SHSE: 688739) operates in the Biotechnology industry within the Health Care sector. The company is valued at $1.27B.
Over the last twelve months the share price has lost 29.8%, trading between 18.91 and 29.63.
Tweenvest scores Liaoning Chengda Biotechnology Co., Ltd. across four factors: quality 75/100, value 38/100, growth 0/100, dividend 74/100. Its strongest factor is quality.
688739 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $1.27B
- Revenue (TTM)
- $189.24M
- P/E
- 144.91
- EPS
- 0.14
- Dividend yield
- 0.48%
- Beta (5Y)
- 0.42
- 52-week high
- CN¥29.63
- 52-week low
- CN¥18.91
- Avg volume (3M)
- —
- Shares outstanding
- 411.25M
- Employees
- —
- Next earnings
- —
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| AbbVie Inc.NYSE: ABBV | $468.22B | $264.96 | +1.20% |
| Amgen Inc.NasdaqGS: AMGN | $237.52B | $439.33 | +1.29% |
| Gilead Sciences, Inc.NasdaqGS: GILD | $181.18B | $146.12 | +1.86% |
| Vertex Pharmaceuticals IncorporatedNasdaqGS: VRTX | $138.91B | $548.05 | +1.44% |
| Regeneron Pharmaceuticals, Inc.NasdaqGS: REGN | $83.28B | $834.04 | +0.90% |
| argenx SEENXTBR: ARGX | $65.85B | €902.00 | +1.90% |
| Moderna, Inc.NasdaqGS: MRNA | $57.92B | $145.13 | +0.04% |
| CSL LimitedASX: CSL | $57.77B | AU$168.30 | -1.69% |
Figures last refreshed Aug 18, 2026.